Described herein are pharmaceutical packaging techniques which avert oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate prescription drugs, these techniques including a syringe by having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with really low permeability to ox